Literature DB >> 10512529

Successful eradication of mucormycosis occurring in a pulmonary allograft.

D A Hunstad1, A H Cohen, J W St Geme.   

Abstract

The zygomycetes are saprophytic fungi that rarely cause disease in the normal human host. In immunocompromised individuals, these organisms can cause invasive infections, collectively called mucormycosis. Mucormycosis is associated with a high mortality rate, especially in organ transplant recipients. In this report, we describe the first case of successfully treated mucormycosis involving a pulmonary allograft. Treatment consisted of surgical excision of the affected lobe and chest wall and lipid-complex amphotericin B. The lipid complex formulation permitted a prolonged course of therapy that was likely critical to eradication of the infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512529     DOI: 10.1016/s1053-2498(99)00033-9

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  5 in total

1.  Rhino-orbital-cerebral mucormycosis.

Authors:  Maria N Gamaletsou; Nikolaos V Sipsas; Emmanuel Roilides; Thomas J Walsh
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Fungal infections in pediatric lung transplant recipients: colonization and invasive disease.

Authors:  Michael Liu; Sarah Worley; George B Mallory; Sarah Arrigain; John Robertson; Marc G Schecter; Okan Elidemir; Lara A Danziger-Isakov
Journal:  J Heart Lung Transplant       Date:  2009-09-26       Impact factor: 10.247

3.  Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation.

Authors:  Lara A Danziger-Isakov; Sarah Worley; Susana Arrigain; Paul Aurora; Manfred Ballmann; Debra Boyer; Carol Conrad; Irmgard Eichler; Okan Elidemir; Samuel Goldfarb; George B Mallory; Marian G Michaels; Peter Michelson; Peter J Mogayzel; Daiva Parakininkas; Melinda Solomon; Gary Visner; Stuart Sweet; Albert Faro
Journal:  J Heart Lung Transplant       Date:  2008-04-24       Impact factor: 10.247

Review 4.  Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?

Authors:  Aline Raquel Voltan; Guillermo Quindós; Kaila P Medina Alarcón; Ana Marisa Fusco-Almeida; Maria José Soares Mendes-Giannini; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2016-08-08

Review 5.  Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread.

Authors:  Shreya Dogra; Akanksha Arora; Aashni Aggarwal; Gautam Passi; Akanksha Sharma; Gurpal Singh; Ravi P Barnwal
Journal:  Front Microbiol       Date:  2022-01-04       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.